Clinical Trials Directory

Trials / Unknown

UnknownNCT06000709

Comparison Between Ultrasound-Guided Genicular Nerve Phenol Neurolysis and Intra-articular Steroid Injections

Randomized, Double-blinded, Comparison Between Ultrasound-Guided Genicular Nerve Phenol Neurolysis and Intra-articular Steroid Injections

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Genicular nerve neurolysis (GN) constitutes a relatively novel technique, whereby different chemical compounds (i.e. alcohol, phenol) are injected in close proximity to the genicular nerves of the knee joint, with the intention to exert a neurolytic effect by denaturing proteins resulting in Wallerian degeneration distal to the lesion. Based on the preliminary evidence and considering the potential benefits of the technique, we hypothesized that ultrasound-guided genicular chemical neurolysis with phenol is superior in terms of pain relief at 3 months, when compared to intra-articular steroid (IAS) injection.

Detailed description

This study will allow us to determine if ultrasound-guided phenol genicular neurolys is superior to intra-articular steroid injection in terms of analgesia and functional outcomes, providing a more effective and long-lasting alternative for patients with chronic knee pain secondary to osteoarthritis

Conditions

Interventions

TypeNameDescription
DRUG6% aqueous phenol1.5 mL of aqueous phenol will be injected at each target genicular nerve under ultrasound guidance
DRUGMethylPREDNISolone 40 MG40 mg of methylprednisolone diluted in 5 mL of 0.9% normal saline will be injected inside the knee joint capsule under ultrasound guidance
DRUGIntraarticular Knee PlaceboSingle injection 1.5 mL of 0.9% normal saline outside the knee joint capsule under ultrasound guidance
DRUGGenicular Nerve Placebo1.5 mL of 0.9% normal saline will be injected subcutaneously at each target genicular nerve under ultrasound guidance

Timeline

Start date
2023-10-20
Primary completion
2024-01-31
Completion
2024-07-31
First posted
2023-08-21
Last updated
2023-10-10

Source: ClinicalTrials.gov record NCT06000709. Inclusion in this directory is not an endorsement.